ReviewImmunity, inflammation and disease2023

Safety and efficacy of elapegademase in patients with adenosine deaminase deficiency: A multicenter, open-label, single-arm, phase 3, and postmarketing clinical study.

Masafumi Onodera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.